Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir?
about
Chloroquine is grossly under dosed in young children with malaria: implications for drug resistanceGuidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerValacyclovir and acyclovir pharmacokinetics in immunocompromised children.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theValacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.Symptom management research in children with cancer.Advances in the antiviral therapy of herpes virus infection in children.Stability of temozolomide in solutions aimed for oral treatment prepared from a commercially available powder for infusion.Individual and population pharmacokinetic compartment analysis: a graphic procedure for quantification of predictive performance.Population pharmacokinetics of acyclovir in children and young people with malignancy after administration of intravenous acyclovir or oral valacyclovir.An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children.
P2860
Q28539103-7DF42918-7D78-4057-BC64-12F087040A1EQ33650105-580324A9-05EC-4014-B09D-F8DFF5024C9AQ33776931-7216A0CE-5432-4226-92FD-DF8BEC3CA053Q34212799-0CBD79F3-E28A-46EE-9EF6-9E53A2250708Q34918273-F1A62C5D-17D3-4B3F-9335-BC4E894B27D5Q35856582-EE5736A4-9C00-4D63-8203-B37E381FC057Q36688958-8CC2F13C-532C-4FD4-908E-0111A728480BQ36855989-18D57F12-E462-4F6F-A0EA-603BAFF58E77Q39478773-4F0084DE-68F6-46C6-9FFA-653096B16A0AQ42286838-5E54CE14-5576-4323-8165-C1B644FC32A5Q44157452-AF94286D-93D5-402C-AD5B-EF962146E986
P2860
Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir?
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Pharmacokinetics of acyclovir ...... stituted by oral valacyclovir?
@en
Pharmacokinetics of acyclovir ...... stituted by oral valacyclovir?
@nl
type
label
Pharmacokinetics of acyclovir ...... stituted by oral valacyclovir?
@en
Pharmacokinetics of acyclovir ...... stituted by oral valacyclovir?
@nl
prefLabel
Pharmacokinetics of acyclovir ...... stituted by oral valacyclovir?
@en
Pharmacokinetics of acyclovir ...... stituted by oral valacyclovir?
@nl
P2093
P2860
P356
P1476
Pharmacokinetics of acyclovir ...... stituted by oral valacyclovir?
@en
P2093
Carina Palm
Mats Kalin
Niklas Pal
Staffan Eksborg
Stefan Söderhäll
P2860
P304
P356
10.1002/MPO.1317
P577
2002-04-01T00:00:00Z